Taken together, ADH4 was simultaneously down-regulated in both HBV-positive HCC tumor tissue and HBV-positive HCC cell line, indicating that ADH4 might be a special biomarker for HBV-associated HCC. The gene discussed is ADH4; the disease is hepatocellular carcinoma.